Updated October 28, 2018 09:30:33 A $2.4 million urine treatment product that uses only water is almost completely effective at treating urinary tract infections, according to a study.
The research, which was published in the Journal of the American Medical Association, found the new formulation significantly reduced the number of infections with urinary tract infection (UTI) in more than 30,000 people.
“The new formulation was the most cost-effective for treating UTI and for the most people, and is a very cost-efficient approach to treating UTIs,” Dr. Jonathan L. Reichenbach, professor of urology at New York University’s Langone Medical Center, said in a statement.
The new product, called a ‘narrow-band’ formulation, is based on a polymer called neomycin, which is already used in many other products.
The new formulation, which Reichenbaum tested, was made of 100 percent neomycin, which has been shown to be very effective at removing bacteria.
It has been known for a while that the treatment of urinary tract bacteria is beneficial, and was recently used in the treatment and prevention of UTIs.
But the new study, which looked at more than 4,000 patients in New York City, found that the new neomycillin-based formulation, combined with a water-based rinse and antibiotic, was more effective than either a placebo or a standard rinse.
“Our results show that using neomyctin-containing solutions for treating urinary infections is effective and cost-competitive,” Reichenbach said.
Reichenbach said that the study is the first of its kind in the United States.
“This is an exciting result because it’s the first to show the effectiveness of a product that has a wide-band formulation,” Reinstein said.
He said that it was not clear if the new product will be used for other conditions or if it would be approved for use in the U.S.
However, the study also showed that the neomycorin-filled solution was effective for treating most other infections, including urinary tract bacterial infections.
The study was funded by the National Institutes of Health (NIH) through a grant from the Howard Hughes Medical Institute (HHMI).
“This study is a tremendous milestone in the field of UTI treatment and will allow us to better understand how to deliver this treatment in the most effective way,” Dr